萬豐
  • Home
  • About Us
    • Background
    • Investment Philosophy
  • Team
  • Portfolio
    • Current
    • Previous
  • News
  • Contact Us
  • English
    • 繁體中文
    • 简体中文
News

AI-Designed Drug AH-001 Complete U.S. Phase I Trial, Demonstrating Excellent Safety and Tolerability

https://blackmarble.com.tw/wp-content/uploads/2023/04/AnHorn1-LOGO-1.png 227 452 Jamie https://blackmarble.com.tw/wp-content/uploads/2017/04/logo_en.png Jamie2025-10-31 16:30:232025-12-18 16:37:45AI-Designed Drug AH-001 Complete U.S. Phase I Trial, Demonstrating Excellent Safety and Tolerability
News

FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kennedy’s Disease

https://blackmarble.com.tw/wp-content/uploads/2023/07/安基1-LOGO.png 227 452 Jamie https://blackmarble.com.tw/wp-content/uploads/2017/04/logo_en.png Jamie2025-10-23 16:53:252025-12-18 17:00:49FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kennedy’s Disease

Categories

  • News (34)

Archives

  • November 2025
  • October 2025
  • June 2024
  • April 2023
  • October 2021
  • August 2021
  • June 2021
  • April 2021
  • January 2021
  • November 2020
  • October 2020
  • August 2020
  • November 2019
  • October 2018
  • February 2018
  • January 2017
  • December 2016
  • November 2016
  • March 2016
  • February 2016
  • July 2015
  • March 2015
© 2017 Copyright - Black Marble Capital Management Co., LTD.
- made by bouncin
Scroll to top